SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending after its strong Q2 earnings beat and raised FY26 revenue guidance, fueling a community debate: many view the AI infrastructure leader as massively undervalued with short squeeze potential, while others focus on persistent margin compression and alleged market manipulation.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending after reporting strong Q4 earnings and optimistic long-term data center growth projections. However, a significant after-hours dip, stemming from Q1 guidance that exceeded consensus but missed elevated AI expectations, fuels community debate between those identifying a 'buy the dip' opportunity and concerns about overvaluation within the semiconductor sector.

BlackRock Institutional Trust Company N.A. - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF (IGV) is experiencing an extreme sell-off and record trading volume, fueled by market concerns that new AI productivity tools threaten traditional software models, prompting community discussion around potential capitulation and the sector being deeply oversold.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG is trending as its community rallies around the "Whats UpDog?" meme, driving strong bullish sentiment and encouraging loading dips, with many proclaiming that "The Dog Stays Up" for this Solana-based project.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is experiencing a sharp selloff following a Q4 earnings miss and an unexpected CEO transition, leading to intense community discussion about whether the stock represents a deeply discounted value opportunity or a company facing long-term structural challenges amid fierce competition.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is trending intensely ahead of its upcoming earnings report, with community sentiment sharply divided between those who see it as significantly oversold given its foundational role in AI and robotics, and others questioning its high valuation amid recent analyst downgrades.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is trending as investor frustration mounts over its continuous price decline and heavy short interest, despite strong fundamentals, analyst upgrades, and a leading position in the emerging Agentic AI space. The community is sharply divided, debating whether ongoing executive stock sales and broad software sector headwinds present a deep value opportunity or a prolonged challenge ahead of upcoming earnings.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending following mixed reactions to its recent earnings, which showed a beat on estimates but reaffirmed conservative 2026 guidance and steep declines in COVID product revenue, leading to investor frustration. Community discussion centers on the potential of its new monthly obesity drug data for future growth despite competitive concerns, alongside widespread calls for leadership change.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is trending following its robust Q3 earnings, which included a surprise non-GAAP profit and raised full-year guidance, sparking widespread community discussion around its strong position in data protection and cyber resilience amidst broader software sector challenges.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings is trending following news of a strategic defense contract in the Asia-Pacific and the acquisition of Rotron Aero, which expands its defense drone capabilities to include long-range attack systems with Blue UAS status. The community is actively discussing how these moves, alongside its indirect stake in a key Department of War drone program, are strategically positioning ONDS in the rapidly growing global defense market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Short Interest Update

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Get Free Report) was the target of a large decline in short interest in December. As of December 31st, there was short interest totaling 4,111,105...

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Recommendation of "Hold" by Brokerages

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Get Free Report) have been given an average rating of "Hold" by the seven brokerages that are presently covering the firm, Marketbeat Ratings...

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Recommendation of "Hold" from Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Get Free Report) has received a consensus rating of "Hold" from the seven brokerages that are currently covering the firm, MarketBeat Ratings reports...

Wall Street Zen Upgrades Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Hold

Wall Street Zen raised shares of Zentalis Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Sunday...

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of "Hold" from Analysts

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Get Free Report) has been given an average recommendation of "Hold" by the eight analysts that are presently covering the company, MarketBeat.com...

FY2025 Earnings Estimate for ZNTL Issued By HC Wainwright

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Stock analysts at HC Wainwright boosted their FY2025 EPS estimates for shares of Zentalis Pharmaceuticals in a note issued to investors on...

Leerink Partnrs Has Positive Outlook of ZNTL FY2025 Earnings

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Research analysts at Leerink Partnrs upped their FY2025 earnings per share estimates for Zentalis Pharmaceuticals in a research report...

Wedbush Expects Higher Earnings for Zentalis Pharmaceuticals

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Equities researchers at Wedbush boosted their FY2025 earnings per share estimates for Zentalis Pharmaceuticals in a research note issued...

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Given New $4.00 Price Target at Morgan Stanley

Morgan Stanley decreased their price objective on shares of Zentalis Pharmaceuticals from $8.00 to $4.00 and set an "equal weight" rating on the stock in a report on Wednesday...

What is Wedbush's Forecast for ZNTL Q1 Earnings?

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Equities researchers at Wedbush issued their Q1 2026 earnings estimates for Zentalis Pharmaceuticals in a research report issued to...

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Zentalis Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $GOOGL earnings on Wednesday?

ZNTL
Zentalis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZNTL News

ZNTLZentalis Pharmaceuticals Inc